Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Removab in Malignant Ascites
NCT00836654Phase 3Completed
- Sponsor
- Neovii Pharmaceuticals
- Start
- Sep 2004
- Primary completion
- Nov 2006
- Modality
- Bispecific Antibodies
01
Overview
A Phase 3 trial of catumaxomab in malignant ascites, sponsored by Neovii Pharmaceuticals. Started Sep 2004; status: completed.
02
Drugs
catumaxomab
03
Conditions
malignant ascites
Beyond the preview
Go deeper on NCT00836654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00836654.